OCUMENSION-B(01477) allocated 280,100 Hong Kong dollars to repurchase 61,500 shares on February 24th.
Ocuvision Biotech-B (01477) announces that on February 24, 2025, the company will invest 28.01...
OCUMENSION-B (01477) announced on February 24, 2025, that the company spent 280,100 Hong Kong dollars repurchasing 61,500 shares at a repurchase price of 4.52-4.57 Hong Kong dollars per share.
Related Articles

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.
Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


